Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · OTC
On Oct. 14, 2026, UEEC is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5379 stocks scored that day.
United Health Products, Inc. is a small-cap company with a market capitalization of $12M. It ranks number 20 by market capitalization among the 24 Orthopedic, Prosthetic & Surgical Appliances & Supplies issuers in our coverage with a current forecast. Its Current Ratio of 0.02x is the lowest of the 24 peers that report one.
A per-ticker accuracy statistic for UEEC is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, UEEC included.
Follow UEEC free90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Orthopedic, Prosthetic & Surgical Appliances & Supplies peers listed below that report each metric.
Reported net income does not reconcile with earnings per share and the share count, so net-income-based ratios are withheld.
| Metric | UEEC | Rank |
|---|---|---|
| Market Cap | $12M | 20/24 |
| EPS | $0.01 | – |
| Metric | UEEC | Rank |
|---|---|---|
| ROIC | 23.7% | 2/21 |
| Tax Rate | 0.0% | – |
| Metric | UEEC | Rank |
|---|---|---|
| Current Ratio | 0.02x | 24/24 |
| Interest Coverage | -3.3x | 10/21 |
| Working Capital | -$4M | 22/22 |
| Metric | UEEC | Rank |
|---|---|---|
| Operating Cash Flow | -$670K | 11/22 |
| Metric | UEEC | Rank |
|---|---|---|
| Operating Income | $0.00M | 9/22 |
| R&D Expense | $120K | 19/19 |
| SG&A Expense | $810K | 19/19 |
| Metric | UEEC | Rank |
|---|---|---|
| Shares Outstanding | 263M | – |
| Total Current Assets | $60K | |
| Cash & Short-term Investments | $20K | |
| Total Liabilities | $5M | |
| Short-term Debt | $3M |
Companies classified under the same SEC industry code as United Health Products, Inc. (Orthopedic, Prosthetic & Surgical Appliances & Supplies): 27 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| UEEC United Health Products, Inc. | ▶ | $12M |
| ISRG Intuitive Surgical Inc | ▼ | $149.10B |
| SNN Smith & Nephew Plc | ▼ | $24.45B |
| STE Steris Plc | ▼ | $21.23B |
| ZBH Zimmer Biomet Holdings, Inc. | ▼ | $17.56B |
| ALGN Align Technology Inc | ▼ | $10.20B |
| MSA Msa Safety Inc | ▼ | $7.01B |
| ESTA Establishment Labs Holdings Inc. | ▲ | $1.74B |
| CDRE Cadre Holdings, Inc. | ▶ | $1.12B |
| ENOV Enovis Corp | ▶ | $1.10B |
| AVR Anteris Technologies Global Corp. | ▼ | $629M |
| SMTI Sanara Medtech Inc. | ▼ | $323M |
| INGN Inogen Inc | ▶ | $168M |
| LAKE Lakeland Industries Inc | ▲ | $97M |
| NTRB Nutriband Inc. | ▲ | $79M |
| APT Alpha Pro Tech Ltd | ▲ | $59M |
| MYO Myomo, Inc. | ▲ | $51M |
| COCH Envoy Medical, Inc. | ▶ | $51M |
| MLSS Milestone Scientific Inc. | ▲ | $30M |
| LFWD Lifeward Ltd. | ▲ | $17M |
| RGNT Regentis Biomaterials Ltd. | ▼ | $8M |
| CLGN Collplant Biotechnologies Ltd | ▲ | $5M |
| FEED Envue Medical, Inc. | ▼ | $510K |
| RBOT Vicarious Surgical Inc. | ▼ | $320K |
| BBLG Bone Biologics Corp | ▲ | N/A |
| CUPR Cuprina Holdings (Cayman) Ltd | ▼ | N/A |
| LGMK Logicmark, Inc. | ▼ | N/A |
MT. LAUREL, NJ - April 6, 2026 (NEWMEDIAWIRE) - United Health Products, Inc. (OTCQB: UEEC) today provided a status update on its discussions with the Food & Drug Administration (FDA) to resolve the ...
MOUNT LAUREL, NJ, March 21, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire-- United Health Products, Inc. (UEEC) today provided an update on the company’s FDA Premarket Approval application process. The ...
About United Health Products Inc. United Health Products, Inc. engages in the development, manufacture, and marketing of wound care products based on its proprietary hemostatic gauze technology. It ...
On Oct. 14, 2026, UEEC is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5379 stocks scored that day.
A per-ticker accuracy statistic for UEEC is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
United Health Products, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
27 issuers in our coverage, UEEC included, share the SEC industry code Orthopedic, Prosthetic & Surgical Appliances & Supplies. The largest are: Intuitive Surgical Inc (ISRG), Smith & Nephew Plc (SNN), Steris Plc (STE), Zimmer Biomet Holdings, Inc. (ZBH), Align Technology Inc (ALGN), Msa Safety Inc (MSA).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.